日本无码

Feature Channels: Clinical Trials

Filters close
Released: 21-May-2024 9:05 AM EDT
Donepezil Does Not Improve Chemotherapy-Related Cognitive Impairment
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine conducted a Phase III randomized, placebo-controlled trial to test donepezil, a cognitive-enhancing medicine used in the treatment of Alzheimer鈥檚 disease. The research team found that donepezil did not improve memory or other cognitive functions in survivors with cancer-related cognitive impairment.

Released: 20-May-2024 10:00 AM EDT
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
Hospital for Special Surgery

Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA).

Released: 20-May-2024 8:55 AM EDT
Clinical trial testing licorice root for prostate cancer begins this spring
University of Illinois Chicago

The University of Illinois Chicago study will be the first to assess whether the natural product has anti-cancer effects that could benefit patients as they await surgical treatment.

Released: 20-May-2024 8:05 AM EDT
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that it has advanced new preclinical studies using Ketamir-2, its differentiated oral ketamine analog, towards clinical development for the treatment of severe post-traumatic stress disorder (PTSD) and other leading mental health disorders and neuropathic pain indications.

日本无码: Tricking the Brain鈥檚 inner GPS: Grid cells responses to the illusion of self-location
Released: 20-May-2024 12:00 AM EDT
Tricking the Brain鈥檚 inner GPS: Grid cells responses to the illusion of self-location
National Research Council of Science and Technology

Dr. Hyuk-June Moon from the Bionics Research Center at the Korea Institute of Science and Technology (KIST), in collaboration with Prof. Olaf Blanke鈥檚 team at the Swiss Federal Institute of Technology Lausanne (EPFL), has successfully induced self-location illusions with multi-sensory virtual reality (VR) in the MRI scanner and observed corresponding changes in the human brain's grid cell activity.

Released: 16-May-2024 11:05 AM EDT
Ochsner Health Highlights Innovative Non-Opioid Pain Therapy Candidate Publication
Ochsner Health

A recent publication in Scientific Reports unveils a potentially groundbreaking non-opioid pain treatment developed by a team led by Dr. Hernan Bazan.

日本无码: Project Could Transform Clinical Trials for Pediatric Brain Tumors
Released: 13-May-2024 6:05 AM EDT
Project Could Transform Clinical Trials for Pediatric Brain Tumors
Children's Hospital Los Angeles

Randomized controlled trials have long been the gold standard for evaluating new therapies. But for pediatric brain tumors, it can be difficult鈥攊f not impossible鈥攖o enroll the large numbers of patients needed for these studies.

日本无码: Sylvester Cancer Launches New Brain Tumor Institute to Personalize Brain Cancer Treatment
Released: 8-May-2024 9:05 PM EDT
Sylvester Cancer Launches New Brain Tumor Institute to Personalize Brain Cancer Treatment
Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center today announced establishment of the Sylvester Brain Tumor Institute. It will focus on personalized medicine approaches for treating all patients with brain tumors.

日本无码: ChatGPT can extract data from clinical notes
Released: 8-May-2024 12:05 PM EDT
ChatGPT can extract data from clinical notes
UT Southwestern Medical Center

ChatGPT, the artificial intelligence (AI) chatbot designed to assist with language-based tasks, can effectively extract data for research purposes from physicians' clinical notes, UT Southwestern Medical Center researchers report in a new study. Their findings, published in NPJ Digital Medicine, could significantly accelerate clinical research and lead to new innovations in computerized clinical decision-making aids.

Released: 6-May-2024 11:30 AM EDT
Society for Clinical Trials Presents E-MOTIVE Trial with Prestigious David Sackett Trial of the Year Award
Society for Clinical Trials

The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to the 鈥漅andomized Trial of Early Detection and Treatment of Postpartum Hemorrhage (E-MOTIVE).鈥

日本无码: MedStar Health Launches Participation in Phase 3 MAGNITUDE 
Gene-Editing Study with First U.S. Heart Patient Treated at 
MedStar Washington Hospital Center
Released: 2-May-2024 8:55 AM EDT
MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart Patient Treated at MedStar Washington Hospital Center
MedStar Washington Hospital Center

The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.

日本无码: 1920_bispecific-antibody-cedars-sinai.jpg?10000
Released: 2-May-2024 12:05 AM EDT
Getting Under the Skin at May 11 Symposium on Melanoma
Cedars-Sinai

The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a free melanoma symposium for patients, caregivers and clinicians.

日本无码: Sylvester Cancer Adding Cellular Therapy to Its Arsenal Against Metastatic Melanoma
Released: 1-May-2024 5:05 PM EDT
Sylvester Cancer Adding Cellular Therapy to Its Arsenal Against Metastatic Melanoma
Sylvester Comprehensive Cancer Center

Patients in South Florida with metastatic melanoma will soon have access to tumor-infiltrating lymphocyte therapy, or TIL. The therapy will be available at Sylvester Comprehensive Cancer Center and will be South Florida鈥檚 only center offering this treatment.

Released: 1-May-2024 2:05 PM EDT
Wake Forest University School of Medicine Approved for $1 Million in PCORI Funding for Patient Subgroup Discovery Study
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine have been approved for a $1 million award by the Patient-Centered Outcomes Research Institute (PCORI) for a methodology study.

日本无码: 1920_cedars-sinai-medical-center-3.jpg?10000
Released: 30-Apr-2024 6:05 PM EDT
April Monthly Research Highlights 日本无码letter
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2024.

Released: 30-Apr-2024 10:05 AM EDT
Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer
Moffitt Cancer Center

Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following initial frontline standard of care immunotherapy that includes an immune checkpoint inhibitor alone or combined with chemotherapy.

日本无码: AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
4-Apr-2024 3:00 PM EDT
AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center presented encouraging findings today from two clinical trials in a plenary session highlighting advances in novel immunotherapy approaches at the American Association for Cancer Research (AACR) Annual Meeting 2024.

   
3-Apr-2024 10:05 AM EDT
AACR: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer
University of California, Los Angeles (UCLA), Health Sciences

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.

Released: 3-Apr-2024 6:05 PM EDT
Tip Sheet: Weight loss drugs and cancer prevention, Fred Hutch at AACR, lymphedema Q&A 鈥 and new vice president and chief nursing officer
Fred Hutchinson Cancer Center

SEATTLE 鈥 April 3, 2024 鈥 Below are summaries of recent Fred Hutchinson Cancer Center research findings, patient stories and other news. If you鈥檙e covering the American Association for Cancer Research (AACR) Annual Meeting, please see our list of and contact to set up interviews.

日本无码: Wilmer Eye Institute Awarded More Than $20 Million for Clinical Trial Investigating Genetic Eye Condition
Released: 3-Apr-2024 10:00 AM EDT
Wilmer Eye Institute Awarded More Than $20 Million for Clinical Trial Investigating Genetic Eye Condition
Johns Hopkins Medicine

The Wilmer Eye Institute, Johns Hopkins Medicine has received two awards totaling more than $20 million from the National Eye Institute at the National Institutes of Health, both of which will be used for a six-year clinical trial investigating a potential treatment for the most common inherited retinal disease, retinitis pigmentosa.

日本无码: 1920_cedars-sinai-plaza-level.jpg?10000
Released: 3-Apr-2024 1:05 AM EDT
Curtis L. Cetrulo, Jr., MD, Selected as Lyon Family Chair in Plastic Surgery
Cedars-Sinai

Curtis L. Cetrulo Jr., MD, vice chair of Research in the Department of Surgery and director of the Division of Plastic Surgery, has been selected as the General William and Willa Dean Lyon Family Chair in Reconstructive and Plastic Surgery.

Released: 2-Apr-2024 4:00 PM EDT
One in five people with cancer participate in medical research studies
Fred Hutchinson Cancer Center

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer in the U.S., or 21.9%, participate in some form of clinical research.

Not for public release

This news release is embargoed until 1-Apr-2024 5:05 PM EDT Released to reporters: 1-Apr-2024 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2024 5:05 PM EDT The 日本无码 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

日本无码:Video Embedded yale-cancer-center-experts-scientists-to-share-vision-and-research-at-leading-conference
VIDEO
Released: 1-Apr-2024 2:05 PM EDT
Yale Cancer Center Experts, Scientists to Share Vision and Research at Leading Conference
Yale Cancer Center/Smilow Cancer Hospital

The five-day session (April 5-10), themed as 鈥淚nspiring Science. Fueling Progress. Revolutionizing Care,鈥 will include new findings from Yale Cancer Center researchers.

Released: 1-Apr-2024 10:05 AM EDT
UChicago Medicine: NCI renews Cancer Center's premier 'Comprehensive' designation amid 50th anniversary celebration
University of Chicago Medical Center

A 'Comprehensive Cancer Center' is the top U.S. designation for cancer research and treatment facilities recognized by high-quality research that leads to major shifts in cancer care.

日本无码: Study explores the future of at-home cancer treatment
Released: 28-Mar-2024 12:00 PM EDT
Study explores the future of at-home cancer treatment
Keck Medicine of USC

A clinical trial from Keck Medicine of USC will test the feasibility of treating non-small cell lung cancer with immunotherapy provided at home.

日本无码: Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types
27-Mar-2024 1:30 PM EDT
Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types
Van Andel Institute

A pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers and other solid tumors, reports a study published today in Science Advances.

日本无码: Gene Therapy Offers Hope for Giant Axonal Neuropathy Patients
Released: 27-Mar-2024 12:05 PM EDT
Gene Therapy Offers Hope for Giant Axonal Neuropathy Patients
UT Southwestern Medical Center

A gene therapy developed by researchers at UT Southwestern Medical Center for a rare disease called giant axonal neuropathy (GAN) was well tolerated in pediatric patients and showed clear benefits, a new study reports. Findings from the phase one clinical trial, published in the New England Journal of Medicine, could offer hope for patients with this rare condition and a host of other neurological diseases.

Released: 27-Mar-2024 10:05 AM EDT
UCI Health celebrates transformational acquisition of four community hospitals
University of California, Irvine

UCI Health, the clinical enterprise of the University of California, Irvine, has completed the acquisition of four hospitals and associated outpatient locations from Tenet Healthcare Corporation.

日本无码: Empowering Minority Cancer Patients: Tips for Advocacy and Support
Released: 27-Mar-2024 9:05 AM EDT
Empowering Minority Cancer Patients: Tips for Advocacy and Support
Rutgers Cancer Institute

Mariam F. Eskander, MD, MPH, surgical oncologist in the Gastrointestinal Oncology Program at Rutgers Institute of New Jersey, offers insight and tips for minority individuals navigating a cancer diagnosis and how we can all work together to mitigate cancer disparities.

日本无码: 10 Facts about Head & Neck Cancers
Released: 27-Mar-2024 9:05 AM EDT
10 Facts about Head & Neck Cancers
Rutgers Cancer Institute

Head and neck cancer is the term used to describe a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses and mouth.

Released: 25-Mar-2024 12:05 PM EDT
Friend or foe: A closer look at the role of health care algorithms in racial and ethnic disparities
Perelman School of Medicine at the University of Pennsylvania

For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.

日本无码: Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in Nih Trial
Released: 21-Mar-2024 11:30 AM EDT
Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in Nih Trial
NIH, National Eye Institute (NEI)

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health.

Released: 21-Mar-2024 7:05 AM EDT
ScienceMedia Welcomes Visionary Leaders to Advisory Board, Paving the Way for a New Era of Innovation
ScienceMedia

ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery in the biotech and pharma industries, announces the formation of its inaugural advisory board.

Released: 20-Mar-2024 5:05 PM EDT
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence
University of California, Los Angeles (UCLA), Health Sciences

A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.

Released: 19-Mar-2024 11:05 AM EDT
ATS 2024 Conference Program is Live! Register Now for Scientific Sessions in Pulmonary, Critical Care and Sleep Medicine
American Thoracic Society (ATS)

The ATS 2024 International Conference Program is now live! Get ready for a series of dynamic scientific programming with presentations covering AI in thoracic medicine, the basic sciences, research breakthroughs and clinical treatment, as well as spotlighting the next generation of innovators in pulmonary, critical care and sleep medicine.

Released: 19-Mar-2024 10:05 AM EDT
Chop Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery
Children's Hospital of Philadelphia

In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity.

日本无码: Role in mitochondrial metabolism paints more complete picture of MCL-1 function
Released: 18-Mar-2024 3:05 PM EDT
Role in mitochondrial metabolism paints more complete picture of MCL-1 function
St. Jude Children's Research Hospital

Scientists at St. Jude Children鈥檚 Research Hospital have uncovered a metabolic role for cell-survival protein MCL-1, potentially explaining previous clinical trial setbacks.

Released: 18-Mar-2024 3:05 PM EDT
Memorial Sloan Kettering Awarded Prestigious NCI Grant to Further Advance CAR T Cell Treatments for Solid Tumors
Memorial Sloan Kettering Cancer Center

A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy鈥痜or solid tumors.

日本无码: Cleveland Clinic-Led Research Concludes Video Laryngoscopy is Most Effective Method for Intubating Patients Undergoing Surgical Procedures
Released: 18-Mar-2024 1:25 PM EDT
Cleveland Clinic-Led Research Concludes Video Laryngoscopy is Most Effective Method for Intubating Patients Undergoing Surgical Procedures
Cleveland Clinic

New Cleveland Clinic-led research provides evidence that video laryngoscopy significantly decreased the number of attempts needed to achieve intubation in adult surgical patients who required single-lumen endotracheal intubation for general anesthesia, compared with direct laryngoscopy. The research was published today in JAMA.

Released: 18-Mar-2024 9:00 AM EDT
St. Baldrick鈥檚 Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children鈥檚 Hospital
Hackensack Meridian Health

St. Baldrick鈥檚 Foundation Awards $50,000 Grant to Expand Pediatric Cancer Clinical Trials at K. Hovnanian Children鈥檚 Hospital

Released: 14-Mar-2024 5:05 PM EDT
UChicago Medicine helps bring first-of-its-kind drug for metabolic liver disease to the clinic
University of Chicago Medical Center

Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.

Released: 14-Mar-2024 3:40 PM EDT
Positive Results from Diabetic Foot Ulcer Clinical Trial Show Dramatic Healing Rate within 12 Weeks or Less Using Novel Omeza庐 Platform and Offloading
Omeza LLC

Omeza庐, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today presented positive interim data from a diabetic foot ulcer (DFU) clinical trial showing that Omeza庐 OCM鈩 plus offloading of weight on the affected foot achieved a 91 percent area reduction (PAR) rate in DFUs within twelve weeks, and a 63 percent PAR within four weeks.

日本无码: New Study Examines if 鈥業noperable鈥 Pancreatic Tumors Can Be Safely Removed
Released: 14-Mar-2024 12:00 PM EDT
New Study Examines if 鈥業noperable鈥 Pancreatic Tumors Can Be Safely Removed
Keck Medicine of USC

A clinical trial from Keck Medicine of USC aims to provide a surgical solution for patients with a form of advanced pancreatic cancer previously considered inoperable.

日本无码: Glaucoma Research Foundation Announces $2.5 Million in Grants to Cure Glaucoma
Released: 14-Mar-2024 7:00 AM EDT
Glaucoma Research Foundation Announces $2.5 Million in Grants to Cure Glaucoma
Glaucoma Research Foundation

鈥淭his is the largest annual research budget in our 46-year history,鈥 said Thomas M. Brunner, GRF President and CEO.

Released: 13-Mar-2024 10:05 AM EDT
Novel Oral Hormone Therapy Shows Promising Results for Prostate Cancer Treatment with Radiation Therapy
University Hospitals Cleveland Medical Center

A high impact study led by Daniel Spratt, MD, Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology.锘

日本无码: Phase 3 CELLEBRATE Trial Testing Regenerative Stem Cell-Based Therapy to Improve Urinary Control for Women
Released: 11-Mar-2024 2:05 PM EDT
Phase 3 CELLEBRATE Trial Testing Regenerative Stem Cell-Based Therapy to Improve Urinary Control for Women
Vanderbilt University Medical Center

The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery.

9-Mar-2024 9:05 AM EST
BIDMC-led trial leads to FDA approval of coronary drug-coated balloons
Beth Israel Deaconess Medical Center

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

日本无码: 1920_hypertension-cedars-sinai.jpg?10000
Released: 8-Mar-2024 10:05 AM EST
Cedars-Sinai Experts Studying Device for Controlling Treatment-Resistant Hypertension
Cedars-Sinai

The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the first on the West Coast to use a new device aimed at lowering blood pressure in patients with difficult-to-treat hypertension.



close
11.16223